Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence.
about
Developing a functional urinary bladder: a neuronal contextResearch Findings on Overactive BladderNeural control of the lower urinary tractNeural mechanisms underlying lower urinary tract dysfunctionThe vitamin D receptor agonist elocalcitol upregulates L-type calcium channel activity in human and rat bladderUrothelial signaling.Inducible knockout mutagenesis reveals compensatory mechanisms elicited by constitutive BK channel deficiency in overactive murine bladder.Neuropeptides in lower urinary tract functionAltered detrusor contractility in MPTP-treated common marmosets with bladder hyperreflexia.The effects of tolterodine on anterior segment and choroidal thickness in patients with overactive bladder syndrome.Urodynamic Effects of Propiverine on Detrusor Overactivity and Abdominal Straining during Voiding in Awake Rats with Intravesical Prostaglandin E(2) Instillation.Flow Starting Point and Voiding Mechanisms Measured by Simultaneous Registrations of Intravesical, Intra-abdominal, and Intraurethral Pressures in Awake RatsStructure-based repurposing of FDA-approved drugs as TNF-α inhibitors.Voltage-gated K(+) channels sensitive to stromatoxin-1 regulate myogenic and neurogenic contractions of rat urinary bladder smooth muscle.Role of potassium ion channels in detrusor smooth muscle function and dysfunctionInterstitial cells: regulators of smooth muscle function.Medical management of overactive bladderP2X2 and P2X3 receptor expression in postnatal and adult rat urinary bladder and lumbosacral spinal cord.Central role of the BK channel in urinary bladder smooth muscle physiology and pathophysiology.New insights into molecular targets for urinary incontinence.Intravesical PGE2 Administration in Conscious Rats as an Experimental Model of Detrusor Overactivity Observed by Simultaneous Registrations of Intravesical and Intraabdominal PressuresLifestyle and health factors associated with progressing and remitting trajectories of untreated lower urinary tract symptoms among elderly men.Muscarinic receptor subtypes in neuronal and non-neuronal cholinergic function.Prolonged poststimulation inhibition of bladder activity induced by tibial nerve stimulation in catsIncreased expression of interleukin-6 family members and receptors in urinary bladder with cyclophosphamide-induced bladder inflammation in female rats.Emerging drugs for treatment of urinary incontinence.Neurogenic detrusor overactivity is associated with decreased expression and function of the large conductance voltage- and Ca(2+)-activated K(+) channelsQuantification of neurological and other contributors to continence in female rats.Molecular expression and pharmacological evidence for a functional role of kv7 channel subtypes in Guinea pig urinary bladder smooth muscleExpression of E-series prostaglandin (EP) receptors and urodynamic effects of an EP4 receptor antagonist on cyclophosphamide-induced overactive bladder in ratsSuppression of bladder overactivity by activation of somatic afferent nerves in the foot.Swimming: effects on stress urinary incontinence and the expression of nerve growth factor in rats following transabdominal urethrolysis.Modulation of smooth muscle tonus in the lower urinary tract: interplay of myosin light-chain kinase (MLCK) and MLC phosphatase (MLCP)Solifenacin/tamsulosin fixed-dose combination therapy to treat lower urinary tract symptoms in patients with benign prostatic hyperplasiaLarge-conductance voltage- and Ca2+-activated K+ channels regulate human detrusor smooth muscle functionAlpha1-, alpha2- and beta-adrenoceptors in the urinary bladder, urethra and prostate.Purinoceptors as therapeutic targets for lower urinary tract dysfunction.Heterogeneous CPA sensitivity of spontaneous excitation in smooth muscle of the rabbit urethra.Diabetic bladder dysfunction.Post-stimulation inhibitory effect on reflex bladder activity induced by activation of somatic afferent nerves in the foot.
P2860
Q26782824-9BFDD430-28CC-4CB5-9B31-DBEBCB1B0F06Q26801459-3AFC4D3B-229A-4DF2-8A12-5862E99ABAD4Q26828785-3BA69156-8817-41DB-BBF9-7E9571D7A67BQ26852088-E385AA13-5A5F-462B-8F9D-EA15E1CCEC10Q28572726-60968E3D-73BF-44E6-90D1-F430A33E7516Q30440958-2414701A-F55C-43E7-84EE-5B8C9C15BECFQ33630889-F90F3A38-19FF-4DC3-9C4A-B9877A190902Q33693944-480B8C33-924F-491A-B96D-CB9D85C2248FQ33698838-5E6FC7DD-7520-4D2F-AA99-EBFC9D559F23Q33727878-D11E6D57-FA7D-450A-A4AB-86A5E89594BCQ33792852-1667F60C-47D0-4465-8BA1-5894763893B9Q33826642-17D03511-7628-425A-8467-641255474770Q33834499-D80A3BF7-05CA-4FB8-8378-7252E8929A91Q33995024-37F1C2EA-FE88-406C-B89F-AECB3C1A84FDQ34029764-5C34AC06-FBC5-4719-B2BF-F2CAFBEC4A84Q34121955-2489D3AF-A8A2-4DF0-96CA-D8B38E23DD5BQ34124065-E63154B8-DA45-4657-A592-275AB1079F04Q34191750-C0436A4D-E1C7-4592-AB12-B37C9D1FBB64Q34201175-72EFB05A-C1D1-4310-8E09-7539BAA5D85EQ34222787-735D922C-9211-48A9-86A0-1AB4ED22B3AAQ34339228-A35286FF-0BFA-44CD-A32A-C9C6856FF543Q34425753-76B0C692-9E38-4E22-AA73-7B853932F7A5Q34552778-739000BC-4B0D-4C8B-B46B-ED28CA6DE60DQ34599993-BE32E139-E8DA-4284-BDAB-D5502AB67522Q34603839-841EC48B-C331-497B-9BCC-C59A34BA3F5FQ34618648-3F6871EB-FE1A-4CF3-BF59-734F98114974Q34826716-074C33CD-5059-4E18-BA10-04BAD3D6768FQ34855653-7FD123C7-0BB2-4EB0-8C6D-B26920B2BDADQ35000941-FCE8146B-5C1A-4FC6-8448-21C59883F681Q35008053-2FD39EDD-D333-48C1-93EC-0F849D5EBBE0Q35088142-E4335BF8-41DD-4557-ABD3-2DBC3FE707C5Q35112714-F9940F49-9192-42FD-A429-5DDBE91A86FDQ35170663-ADD57769-CF9C-4B27-8057-B08FE59E6FC9Q35212816-BA8883FA-60F7-4008-A9EE-F4D297FF5C25Q35321958-3BE1F32F-E650-48B6-B086-4922A93A8524Q35545711-553E7128-C463-4905-8FAE-BA7FB8607E17Q35545723-9D377BED-1274-40C6-95B5-FB0209A69D56Q35545914-521A6AE4-AADA-4743-9536-16F30BC8BC6AQ35591952-6BA5B453-2BDE-4C4E-A381-B39D7CCBD846Q35613101-B94CFE34-37A1-4579-A1F8-D5F319652A3F
P2860
Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence.
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
Pharmacology of the lower urin ...... ments of urinary incontinence.
@ast
Pharmacology of the lower urin ...... ments of urinary incontinence.
@en
Pharmacology of the lower urin ...... ments of urinary incontinence.
@nl
type
label
Pharmacology of the lower urin ...... ments of urinary incontinence.
@ast
Pharmacology of the lower urin ...... ments of urinary incontinence.
@en
Pharmacology of the lower urin ...... ments of urinary incontinence.
@nl
prefLabel
Pharmacology of the lower urin ...... ments of urinary incontinence.
@ast
Pharmacology of the lower urin ...... ments of urinary incontinence.
@en
Pharmacology of the lower urin ...... ments of urinary incontinence.
@nl
P356
P1476
Pharmacology of the lower urin ...... ments of urinary incontinence.
@en
P2093
Karl-Erik Andersson
P304
P356
10.1124/PR.56.4.4
P50
P577
2004-12-01T00:00:00Z